NSN Parts Associated with NSN 6505-01-656-4670 (6505016564670) of Fentanyl Transdermal System- Submit a Quote
NSN 6505-01-656-4670 is a type of Fentanyl Transdermal System component is now available in stock at One Click Purchasing. NSN codes are a unique numeric serial number assigned by the Defense Logistics Agency (DLA) for all items acquired, stocked, and circulated within the federal supply chain. With NSNs, identifying items is made much easier, ensuring simplified purchasing processes where customers can guarantee that they only procure exact items as necessary.
At One Click Purchasing, owned and operated by ASAP Semiconductor LLC, we prioritize the supply of high-quality, authenticated NSN parts with NSN 6505-01-656-4670 at competitive prices. With an extensive supply-chain network, we guarantee the fastest turnaround times in the industry and a 95% on-time delivery track record. If you would like to obtain a rapid quote for parts with the NSN 6505-01-656-4670, please complete the instant RFQ form below, and a dedicated representative will contact you shortly.
Information of NSN 6505-01-656-4670 (6505016564670)
Alternate NSN : 6505-01-656-4670 |
Manufacturers : mylan pharmaceuticals inc |
CAGE Code : 3KJG9 |
Item Name : Fentanyl Transdermal System |
NIIN : 016564670 |
NCB Code : USA (01) |
Part Number's List for NSN 6505-01-656-4670, 6505016564670
Part No | Manufacturer | Item Name | RFQ |
---|---|---|---|
NDC00378-9126-98 | Avl |
Product Details of NSN 6505016564670
MRC | Criteria | Characteristic |
---|---|---|
CBBL | FEATURES PROVIDED | INDIVIDUALLY SEALED |
CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | DURAGESIC-62.5 (FENTANYL TRANSDERMAL SYSTEM) 62.5MCG/HR, 5S |
FEAT | SPECIAL FEATURES | ROUTE: TRANSDERMAL; DOSE FORM: PATCH, TRANSDERMAL 72 HOURS; STRENGTH: 62.5 MCG/HOUR; DEA CONTROLLED II SUBSTANCE; INDIVIDUALLY SEALED; CONTAINS FIVE (62.5 MCG/HR) TRANSDERMAL SYSTEMS; STORE IN ORIGINAL UNOPENED POUCH; STORE UP TO 20 C TO 25 C (68 F TO 77 F); STRICT ADHERENCE TO THE RECOMMENDED HANDLING AND DISPOSAL INSTRUCTIONS ON PRODUCT INSERT IS OF THE UTMOST IMPORTANCE TO PREVENT ACCIDENTAL EXPOSURE; EXPOSURE OF FENTANYL TRANSDERMAL SYSTEM APPLICATION SITE AND SURROUNDING AREA TO DIRECT EXTERNAL HEAT SOURCES, SUCH AS HEATING PADS, SAUNAS, HOT TUBS AND HEATED WATER BEDS MAY INCREASE FENTANYL ABSORPTION AND RESULT IN FATAL OVERDOSE OF FENTANYL AND DEATH; PATIENTS WHO DEVELOP FEVER OR INCREASED CORE BODY TEMPERATURE DUE TO STRENOUS EXERTION ARE ALSO AT RISK FOR INCREASED FENTANYL EXPOSURE AND MAY REQUIRE AN ADJUSTMENT IN THE DOSE OF FENTANYL TRANSDERMAL SYSTEM TO AVOID OVERDOSE |
CRYC | CONTROLLED SUBSTANCE CLASSIFICATION | SCHEDULE II |
CSLZ | USUAL DOSE | 62.5 MCG/HR |